Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 13;7(7):1093-1096.
doi: 10.3889/oamjms.2019.252. eCollection 2019 Apr 15.

Diagnostic Value of Platelet-To-Lymphocyte Ratio in Prostate Cancer

Kharisma Prasetya Adhyatma  1 , Syah Mirsya Warli  1
Affiliations

Diagnostic Value of Platelet-To-Lymphocyte Ratio in Prostate Cancer

Kharisma Prasetya Adhyatma et al. Open Access Maced J Med Sci. .

Abstract

Background: Previous studies demonstrated the promising value of platelet-to-lymphocyte (PLR) in prostate cancer.

Aim: This study was conducted to evaluate its pre-biopsy values in predicting prostate cancer.

Methods: We included all benign prostatic hyperplasia (BPH) and prostate cancer (PCa) patients who underwent a prostate biopsy in Adam Malik Hospital between August 11th 2011 and August 31st 2015. The relationship between pre-biopsy variables which could be affecting the percentage of prostate cancer risk was evaluated, including age, prostate-specific antigen (PSA) level, and prostate volume (EPV). The PLR was calculated from the ratio of related platelets with their absolute lymphocyte counts. The values then analysed to evaluate their associations with the diagnosis of BPH and PCa.

Results: As many as 298 patients consisted of 126 (42.3%) BPH and 172 PCa (57.7%) patients are included in this study. Mean age for both groups are 66.36 ± 7.53 and 67.99 ± 7.48 years old (p = 0.64), respectively. There are statistically significant differences noted from PSA (19.28 ± 27.11 vs 40.19 ± 49.39), EPV (49.39 ± 23.51 vs 58.10 ± 30.54), PLR (160.27 ± 98.96 vs 169.55 ± 78.07), and NLR (3.57 ± 3.23 vs 4.22 ± 2.59) features of both groups (p < 0.05). The AUC of PLR is 57.9% with a sensitivity of 56.4% and specificity of 55.6% in the cut-off point of 143 (p = 0.02). Besides, the NLR cut-off point of 3.08 gives 62.8% AUC with 64.5% sensitivity and 63.5% specificity. We asked for permission from the preceding authors of Indonesian Prostate Cancer Risk Calculator (IPCRC) and calculated its value from 98 randomised patients consist of 45 (45.92%) BPH and 53 (54.08%) PCa. We found a comparable value between PLR/NLR with IPCRC in predicting prostate cancer (AUC of 67.6%, 75.3%, and 68.4%, respectively) with a statistically significant difference of all value in both groups (p < 0.05).

Conclusions: PLR gives promising value in predicting prostate cancer in suspected patients. We suggest a further prospective study to validate its diagnostic values so it can be used as applicable routine calculation.

Keywords: Diagnostic; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Prostate cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The ROC Curves of PLR and PSA
Figure 2
Figure 2
The ROC Curves of PLR and IPCRC Score
See this image and copyright information in PMC

References

    1. (IARC) G. Prostate Cancer:Estimated Incidence, Mortality, and Prevalence Worldwide in 2012. IARC. 2012
    1. Gokce MI, Hamidi N, Suer E, Tangal S, Huseynov A, Ibis A. Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology:Results of 1836 patients. Canadian Urological Association journal =Journal de l'Association des urologues du Canada. 2015;9(11-12):E761–5. https://doi.org/10.5489/cuaj.3091 PMid:26600880 PMCid:PMC4639422. - PMC - PubMed
    1. McDonald AC, Vira MA, Vidal AC, Gan W, Freedland SJ, Taioli E. Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey. The Prostate. 2014;74(5):561–7. https://doi.org/10.1002/pros.22782 PMid:24435840 PMCid:PMC4380881. - PMC - PubMed
    1. Kawahara T, Fukui S, Sakamaki K, Ito Y, Ito H, Kobayashi N, et al. Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy. Oncotarget. 2015;6(31):32169–76. https://doi.org/10.18632/oncotarget.5081 PMid:26359354 PMCid:PMC4741667. - PMC - PubMed
    1. Yuksel OH, Urkmez A, Akan S, Yldirim C, Verit A. Predictive Value of the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate Cancer. Asian Pacific journal of cancer prevention :APJCP. 2015;16(15):6407–12. https://doi.org/10.7314/APJCP.2015.16.15.6407 PMid:26434851. - PubMed

LinkOut - more resources